Patents/Inventors

Daniel Christopher Rowe

Ridgefield, CTUS1 patent

2 Patents

US121460002024
Bispecific and Tetravalent CD137 and FAP Molecules for the Treatment of Cancer
Boehringer Ingelheim International GmbH
0 cites
US119998002024
Bispecific and Tetravalent CD137 and FAP Molecules for the Treatment of Cancer
Boehringer Ingelheim International GmbH
0 cites